Relax Your Mind

Relaxation Techniques

Get Instant Access

The control of vascular tone is multifactorial. The autonomic nervous system, intrinsic vascular smooth muscle reflexes and the endothelium all play a role in maintaining blood flow to an organ. Defects in one parameter are counterbalanced by another, making it difficult to understand the primary pathology. Prospective studies in healthy and diseased pregnancy will help our understanding of cardiovascular change during pregnancy and in those women who go on to develop pre-eclampsia.

One of the most important adaptations made by the endothelium during healthy pregnancy is increased nitric oxide synthase (NOS) activity, which is stimulated by the gestational increase in estradiol levels. During pregnancy, maternal organs vary in their degree of vasodilatation, possibly reflecting the variable expression of eNOS in their vasculature. Blood flow to the uterus in particular increases secondary to increased NOS activity. A healthy endothelium also prevents hemostasis and inflammatory activity. When the endothelium is damaged, the vasodilatory, anti-thrombotic and anti-inflammatory roles of the endothelium are attenuated. This leads to reduced maternal organ blood flow due to vasoconstriction, microthrombi and local inflammation, all of which are present in affected organs during pre-eclampsia.

The risk factors for pre-eclampsia (all except smoking) are similar to those for cardiovascular disease in later life. It is clear therefore that some women who go on to develop pre-eclampsia have pre-existing endothelial dysfunction. They are vulnerable to even a mild inflammatory stress or increased antiangiogenic response. The source of this anti-endothelial stress appears to be a poorly implanted placenta, but may also involve a hormone-induced metabolic state that is damaging to the endothelium. Further understanding of the clinical spectrum of pre-eclampsia will allow us to customize anti-pre-eclampsia prophylaxis according to maternal and possibly paternal phenotype.


Ahmed, A., Li, X.F., Dunk, C., etal. (1995). Co-localization of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors, 12, 235-43.

Ajne, G., Wolff, K., Fyhrquist, F., et al. (2003). Endothelin converting enzyme (ECE) activity in normal pregnancy and pre-eclampsia. Hypertens. Pregn., 22, 215-24.

Anumba, D.O.C., Robson, S.C., Boys, R.J. and Ford, G.A. (1999). Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am. J. Physiol., 277, H848-54.

Ashworth, J. R., Warren, A.Y., Baker, P.N. and Johnson, I. R. (1996). Endothelium-dependent relaxation in omental and myometrial resistance arteries in pregnant and non-pregnant women. Am. J. Obstet. Gynecol., 175, 1307-12.

Ashworth, J. R., Warren, A. Y., Baker, P. N. and Johnson, I. R. (1997). Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br. J. Obstet. Gynecol., 104, 1152-8.

Assali, N. S. and Prystowsky, H. (1950). Studies on autonomic blockade. I. Comparison between the effects of tetraethylammonium chloride (TEAC) and high selective spinal anesthesia on blood pressure of normal and toxemic pregnancy. J. Clin. Invest., 29, 1354-66.

Bagnall, A. J. and Webb, D. J. (2000). The endothelin system: physiology. In Vascular Endothelium in Human Physiology and Pathophysiology, eds. P.J.T. Vallance and D. J. Webb. The Netherlands: Harwood Academic Publishers.

Baker, P.N., Krasnow, J., Roberts, J.M. and Yeo, K.T. (1995). Elevated serum levels of vascular endothelial growth factor in patients with pre-eclampsia. Obstet. Gynecol., 86, 815-21.

Barden, A., Graham, D., Beilin, L.J., et al. (1997). Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin. Sci., 92, 37-44.

Boccardo, P., Soregaroli, M., Aiello, S., et al. (1996). Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia. Br. J. Obstet. Gynaecol., 103, 879-86.

Bonnar, J. (1987). Haemostasis and coagulation disorders in pregnancy. In Haemostasis and Thrombosis, eds. A. L. Bloom and D. P. Thomas. Edinburgh: Churchill Livingstone, pp. 570-84.

Boulanger, C. and Luscher, T. F. (1990). Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin. Invest., 85, 587-90.

Bower, S., Bewley, S. and Campbell, S. (1993). Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet. Gynecol., 82, 78-83.

Bremme, K., Ostlund, E., Almquist, I., et al. (1992). Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet. Gynecol., SC, 132-7.

Brockelsby, J., Hayman, R., Ahmed, A., et al. (1999). VEGF via VEGF receptor-1 (Flt-1) mimics pre-eclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of pre-eclampsia. Lab. Invest., 79, 1101-11.

Brown, M.A. and Gallery, E.D.M. (1994). Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications. Baillieres Clin. Obst. Gynaecol., S, 287-310.

Calver, A., Collier, J., Leone, A., Moncada, S. and Vallance, P. (1993). Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arter-iolar bed of healthy volunteers. J. Hum. Hypertens., 7, 193-4.

Cameron, I., van Papendorp, C. L., Palmer, R. M. J., et al. (1993). Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens. Preg., 12, 85-92.

Castro, L.C., Hobel, C.J. and Gornbein, J. (1994). Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am. J. Obstet. Gynecol., 171, 1642-51.

Celermajer, D. S., Sorensen, K. E., Gooch, V. M., et al. (1992). Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 34C, 1111-15.

Chapman, A. B., Abraham, W. T., Zamudio, S., etal. (1998). Temporal relationships between hormonal and hemo-dynamic changes in early human pregnancy. Kidney Int., 54, 2056-63.

Chavarria, M. E., Lara-Gonzalez, L., Gonzalez-Gleason, A., et al. (2002). Maternal plasma cellular fibronectin concentrations in normal and pre-eclamptic pregnancies: a longitudinal study for early prediction of pre-eclampsia. Am. J. Obstet. Gynecol., 1S7, 595-601.

Chavarria, M. E., Lara-Gonzalez, L., Gonzalez-Gleason, A., etal. (2003). Prostacyclin/thromboxane early changes in pregnancies that are complicated by pre-eclampsia. Am. J. Obstet. Gynecol., 1SS, 986-92.

Chen, D. B., Bird, I. M., Zheng, J. and Magness, R. R. (2004). Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology, 145, 113-25.

Chen, G., Suzuki, H. and Weston, A. H. (1988). Acetylcho-line releases endothelium-derived hyperpolarising factor and EDRF from rat blood vessels. Br. J. Pharmacol., 95, 1165-74.

Chen, G., Wilson, R., Wang, S.H., et al. (1996). Tumour necrosis factor alpha (TNF-a) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol., 104, 154-9.

Chirico, S., Smith, C., Merchant, C., et al. (1993). Lipid peroxidation in hyperlipidaemic patients: a study of plasma using an HPLC-based thiobarbituric acid test. Free Rad. Res. Commun., 19, 51-7.

Clark, B.A., Ludmire, J., Epstein, F. H., etal. (1997). Urinary cGMP, endothelin, and prostaglandin E2 in normal pregnancy and preeclampsia. Am. J. Perinatal., 14, 559-62.

CLASP (Collaborative Low Dose Aspirin Study in Pregnancy) Collaborative group. (1994). CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet, 343, 619-29.

Cockell, A. P. and Poston, L. (1997a). Flow mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension, 30, 247-51.

Cockell, A. P. and Poston, L. (1997b). 17ß estradiol stimulates flow-induced vasodilatation in isolated small mesenteric arteries from prepubertal female rats. Am.. J. Obstet. Gynaecol., 177, 1432-8.

Cockell, A. P., Learmont, J. G., Smarason, A. L., etal. (1997). Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial cell function. Br. J. Obstet. Gynaecol., 104, 235-40.

Coleman, H.A., Tare, M. and Parkington, H.C. (2001). K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J. Physiol., 531, 359-73.

Conrad, K.P. and Vernier, V.A. (1989). Plasma levels, urinary excretion and metabolic production of cGMP during gestation in rats. Am. J. Physiol., 257, R847-53.

Conrad, K.P. and Benyo, D.F. (1997). Placental cytokines and the pathogenesis of pre-eclampsia. Am. J. Reprod. Immunol., 37, 240-9.

Conrad, K.P., Joffe, G.M., Kruszyna, H., et al. (1993). Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J., 7, 566-71.

Coomerasamy, A., Honest, H., Papaionnou, S., et al. (2003). Aspirin for prevention of pre-eclampsia in women with historical risk factors: a systematic review. Obstet. Gynecol., 101, 1318-32.

Curtis, N.E., Gude, N.M., King, R.G., etal. (1995). Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens. Preg., 23, 1096-105.

Danielson, L.A. and Conrad, K.P. (1995). Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J. Clin. Investig., 96, 482-90.

Davenport, A. P., Ashley, M.J., Easton, P., et al. (1990). A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin. Sci., 78, 261-4.

Davidge, S. T. (2001). Prostaglandin H synthase and vascular function. Circ. Res., 89, 650-60.

Davidge, S.T., Signorella, A.P., Lykins, D.L., etal. (1996). Evidence of endothelial activation and endothelial activators in cord blood of infants of pre-eclamptic women. Am. J. Obstet. Gynecol., 175, 1301-6.

Davison, J. M. (1984). Renal haemodynamics and volume homeostasis in pregnancy. Scand. J. Clin. Lab. Invest., 169(Suppl.), 15-27.

Dayoub, H., Achan, V., Adimoolam, S., et al. (2003). Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis. Genetic and physiological evidence. Circulation, 108, 3042-7.

de Boer, K., ten-Cate, J.W., Sturk, A., et al. (1989). Enhanced thrombin generation in normal and hypertensive pregnancy. Am. J. Obstet. Gynecol., 160, 95-100.

Dunk, C. and Ahmed, A. (2001). Expression of VEGF-c and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol. Histopathol., 16, 359-75.

Dunlop, W. (1981). Serial changes in renal haemody-namics during normal human pregnancy. Br. J. Obstet. Gynecol., 88, 1-9.

Easterling, T. R., Watts, H., Schumucker, B. C. and Benedettie, T.J. (1987). Measurement of cardiac output during pregnancy: validation of Doppler technique and clinical observations in pre-eclampsia. Obstet. Gynecol., 69, 845-50.

Edwards, G., Dora, K.A., Gardener, M. J., etal. (1998). K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature, 396, 269-72.

Edwards, G., Thollon, C., Gardener, M. J., etal. (2000). Role of gap junctions and EETs in endothelium-dependent hyperpolarisation of porcine artery. Br. J. Pharmacol., 129, 1145-54.

Endresen, M. J., Tosti, E., Lorentzen, B. and Henriksen, T. (1995). Sera of preeclamptic women is not cytotoxic to endothelial cells in culture. Am. J. Obstet. Gynecol., 172, 196-201.

Farhat, M.Y., Lavigne, M.C. and Ramwell, P.W. (1996). The vascular protective effects of estrogen. FASEB J., 10, 615-24.

Feletou, M. and Vanhoutte, P.M. (1988). Endothelium-dependent hyperpolarisation of canine coronary smooth muscle. Br. J. Pharmacol., 93, 515-24.

Fickling, S.A., Williams, D., Vallance, P., et al. (1993). Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet, 342, 242-3.

Fitzgerald, D.J., Rocki, W., Murray, R., et al. (1990). Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet, 335, 751-4.

Flavahan, N.A. and Vanhoutte, P.M. (1995). Endothelial cell signalling and endothelial cell dysfunction. Am. J. Hypertens., 8, 28S-41S.

Ford, G.A., Robson, S.C. and Mahdy, Z.A. (1996). Superficial hand vein responses to NG-monomethyl-L-arginine in post-partum and non-pregnant women. Clin. Sci., 90, 493-7.

Fostermann, U., Closs, E.I., Pollock, J. S., et al. (1994). Nitric oxide synthase isoenzymes. Characterization, purification, molecular cloning, and functions. Hypertension, 23, 1211-31.

Freeman, B. A., Gutierrez, H. and Rubbo, H. (1995). Nitric oxide: a central regulatory species in pulmonary oxidant reactions. Am. J. Physiol., 268, L697-8.

Fried, G. and Samuelson, U. (1991). Endothelin and neuropetide Y are vasoconstrictors in human uterine blood vessels. Am. J. Obstet. Gynecol., 164, 1330-6.

Furchgott, R. F. (1988). Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis in inorganic nitrite and the endothelium-derived relaxing factor in nitric oxide. In Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, ed. P. M. Vanhoutte. New York: Raven, pp. 401-14.

Furchgott, R.F. and Vanhoutte, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J., 3, 2007-18.

Furchgott, R. and Zawadzki, D. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-6.

Gargett, C. E., Bucak, K., Zaitseva, M., et al. (2002). Estrogen receptor-alpha and -beta expression in micro-vascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Mol. Hum. Reprod., 8, 770-5.

Garland, C.J., Plane, F., Kemp, B.K. and Cox, T.M. (1995). Endothelium-dependent hyperpolarisation: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.

Gerber, R.T., Anwar, M.A. and Poston, L. (1998). Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br. J. Pharmacol., 125(3), 455-60.

Goodrum, L., Saade, G., Jahoor, F., et al. (1996). Nitric oxide production in normal human pregnancy. J. Soc. Gynecol. Investig., 3, 97A.

Goonasekera, C.D., Rees, D.D., Woolard, P., et al. (1997). Nitric oxide synthase inhibitors and hypertension in children and adolescents. J. Hypertens., 15, 901-9.

Granger, J. P., Alexander, B.T., Llinas, M.T., et al. (2001). Pathophysiology of hypertension during pre-eclampsia. Linking placental ischaemia with endothelial dysfunction. Hypertension, 38(Suppl.), 718-22.

Greer, I.A., Haddad, N.G., Dawes, J., et al. (1989). Neutrophil activation in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol., 96, 978-82.

Halligan, A., O'Brien, E., O'Malley, K., etal. (1993). 24 hour ambulatory blood pressure measurement in the primigravid population. J. Hypertens., 11, 869-73.

Hashimoto, M., Akishita, M., Eto, M., et al. (1995). Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation, 92, 3431-5.

Hecker, M., Bara, A. T., Bauersachs, J. and Busse, R. (1994). Characterization of endothelium-derived hyperpolariz-ing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. (Lond.), 481, 407-14.

Hill, C.E., Phillips, J.K. and Sandow, S.L. (2001). Heterogeneous control of blood flow amongst different vascular beds. Medic. Res. Rev., 21, 1-60.

Holden, D.P., Fickling, S.A., StJ. Whitley, G. and Nussey, S. S. (1998). Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and pre-eclampsia. Am. J. Obstet. Gynecol., 178, 551-6.

Hubel, C.A., McLaughlin, M.K., Evans, R.W., etal. (1996). Fasting serum triglycerides, free fatty acids and mal-ondialdehyde are increased in pre-eclampsia, are positively correlated, and decrease within 48 hours post partum. Am. J. Obstet. Gynecol., 174, 975-82.

Ignarro, L.J., Byrns, R.E. and Wood, K.S. (1988). Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, ed. P. M. Vanhoutte. New York: Raven, pp. 401-14.

Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., et al. (2003). Phase II, randomised trial comparing bevacizu-mab plus fluorouracil (FU)/leucovorin (LV) and FU/LV alone in patients with metastatic colorectal cancer. J. Clin. Oncol., 21, 60-5.

Kakimoto, Y. and Akazawa, S. (1970). Isolation and identification of NG,NG- and NG,N'G-dimethylarginine, N-epsilon-mono, di-, and trimethyllysine, and gluco-sylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J. Biol. Chem., 245, 5751-8.

Kenny, L.C., Baker, P.N., Kendall, D.A., et al. (2002a). Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin. Sci., 103, 67-73.

Kenny, L.C., Baker, P.N., Kendall, D.A., etal. (2002b). The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women. Br. J. Pharmacol., 136, 1085-8.

Killam, A.P., Rosenfeld, C.R., Battaglia, F.C., etal. (1973). Effect of estrogens on the uterine blood flow of oophorectomised ewes. Am. J. Obstet. Gynecol., 115, 1045-52.

Kitching, A.R., Kong, Y.Z., Huang, X.R., et al. (2003). Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol., 14, 1487-95.

Knock, G.A. and Poston, L. (1996). Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am. J. Obstet. Gynecol., 175, 1668-74.

Koga, K., Osuga, Y., Yoshino, O., et al. (2003). Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J. Clin. Endocrinol. Metab., 88, 2348-51.

Kopp, L., Paradiz, G. and Tucci, J.R. (1977). Urinary excretion of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during and after pregnancy. J. Clin. Endocrinol. Metabol., 44, 590-4.

Kruithof, E.K., Tran-Thang, C., Gudinchet, A., etal. (1987). Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood, 69, 460-6.

Kublickiene, K. R., Kublickas, M., Lindblom, B., Lunell, N.-O. and Nisell, H. (1997a). A comparsion of myogenic and endothelial properties of myometrial and resistance vessels in late pregnancy. Am. J. Obstet. Gynecol., 176, 560-6.

Kublickiene, K.R., Cockell, A. P., Nisell, H. and Poston, L. (1997b). Role of nitric oxide in the regulation of vascular tone in pressurised and perfused resistance myometrial arteries from term pregnant women. Am. J. Obstet. Gynecol., 177, 1263-9.

Kublickiene, K. R., Gruenwald, C., Lindblom, B. and Nisell, H. (1998). Myogenic and endothelial properties of myometrial resistance arteries from women with pre-eclampsia. Hypertens. Preg., 17, 271-82.

Kuchan, M.J. and Frangos, J.A. (1994). Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am. J. Physiol., 266, C628-36.

Kupfermine, M., Peaceman, A.M., Wigton, T.R., et al. (1994). Tumour necrosis factor a is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am. J. Obstet. Gynecol., 170, 1752-9.

Learmont, J. G., Cockell, A. P., Knock, G. A. and Poston, L. (1996). Myogenic and flow mediated responses in isolated mesenteric small arteries from pregnant and non-pregnant rats. Am. J. Obstet. Gynecol., 174, 1631-6.

Leiper, J. and Vallance, P. (1999). Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res., 43, 542-8.

Leiper, J.M., Santa Maria, J., Chubb, A., et al. (1999). Identification of two human dimethylarginine di-methyl-aminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J., 343, 209-14.

Letsky, E.A. (1995). Coagulation defects. In Medical Disorders in Obstetric Practice, ed. M. de Swiet. Oxford: Blackwell Scientific, pp. 71-115.

Levine, R.J., Maynard, S.E., Cong, Qian, et al. (2004). Circulating angiogenic factors and the risk of pre-eclampsia. N. Engl. J. Med., 350, 672-83.

Levine, R. J., Chun, Lam, Cong, Qian, et al. (2006). Soluble endoglin and other circulating antiangiogenic factors in pre-eclampsia. N. Engl. J. Med., 355, 992-1005.

Lincoln, J. and Burnstock, G. (1990). Neural-endothelial interactions in control of local blood flow. In The Endothelium: An Introduction to Current Research, ed. J. D. Warren. New York: Wiley-Liss, Inc., pp. 21-32.

Luscher, T. F. and Barton, M. (1997). Biology of the endothelium. Clin. Cardiol., 20, 3-10.

Luscher, T.F. and Vanhoutte, P.M. (1990). The Endothe-lium: Modulator of Cardiovascular Function. Boca Raton, FL: CRC Press.

Lyall, F. and Greer, I. A. (1996). The vascular endothelium in normal pregnancy and pre-eclampsia. Rev. Reprod., 1 , 107-16.

Lyall, F., Greer, I. A., Boswell, F., et al. (1994). The cell adhesion molecule VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br. J. Obstet. Gynaecol., 101, 485-7.

Lyall, F., Greer, I.A., Boswell, F. and Fleming, R. (1997). Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br. J. Obstet. Gynaecol., 104, 223-8.

MacRitchie, A.N., Jun, S.S., Chen, Z., et al. (1997). Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ. Res., 81, 355-62.

Magness, R. R., Shaw, C. E., Phernetton, T. M., et al. (1997). Endothelial vasodilator production by uterine and systemic arteries. II Pregnancy effects on NO synthase expression. Am. J. Physiol., 272, H1730-40.

Mahdy, Z., Otun, H. A., Dunlop, W. and Gillespie, J. I. (1998). The responsiveness of isolated human hand vein endothelial cells in normal pregnancy and in pre-eclampsia. J. Physiol., 508, 609-17.

Mantovani, A. (1997). The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs, 54, 15-23.

Manyonda, I.T., Slater, D.M., Fenske, C., et al. (1988). A role for noradrenaline in pre-eclampsia: towards a unifying hypothesis for the pathophysiology. Br. J. Obstet. Gynaecol., 105, 641-8.

Marx, N., Imhof, A., Froehlich, J., et al. (2003). Effect of rosiglitazone treatment on soluble CD40L in patients with type II diabetes and coronary artery disease. Circulation, 107, 1954-7.

Masaki, T. (1989). The discovery, the present state, and future prospects of endothelin. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), S1-4.

Maynard, S. E., Min, J. Y., Merchan, J., et al. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J. Clin. Investig., 111, 649-58.

McCarthy, A.L., Taylor, P., Graves, J., et al. (1994). Endothelium dependent relaxation of human resistance arteries in pregnancy. Am. J. Obstet. Gynecol., 171, 1309-15.

McDermott, J. R. (1976). Studies on the catabolism of NG-methylarginine, NG,NG-dimethylarginine and NG,NG-dimethylarginine in the rabbit. Biochem. J., 154, 179-84.

Mendelsohn, M.E. and Karas, R. H. (1994). Estrogen and the blood vessel wall. Curr. Opin. Cardiol., 9, 619-26. Mills, J.L., DerSimonian, R., Raymond, E., etal. (1999). Prostacyclin and thromboxane changes predating clinical onset of pre-eclampsia. A multicenter prospective study. J. Am. Med. Ass., 282, 356-62. Miyazaki, H., Matsuoka, H., Cooke, J.P., et al. (1999). Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation, 99, 1141-6. Molnar, M. and Hertelendy, F. (1995). Signal transduction in rat myometrial cells: comparison of the actions of endothelin-1, oxytocin and prostaglandin F2 alpha. Eur. J. Endocrinol., 133, 467-74. Molnar, M., Suto, T., Toth, T., et al. (1994). Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, throm-bocytopaenia and intrauterine growth retardation. Am. J. Obstet. Gynecol., 170, 1458-66. Mombouli, J.V. and Vanhoutte, P.M. (1999). Endothelial dysfunction: from physiology to therapy. J. Mol. Cell. Cardiol., 31, 61-74. Moncada, S. (1982). Biological importance of prostacyclin.

Br. J. Pharmacol., 76, 3-31. Moncada, S. (1992). The L-arginine-nitric oxide pathway.

Acta Physiol. Scand., 145, 201-27. Moncada, S. and Higgs, E. A. (1993). The L-arginine-nitric oxide pathway. NJEM, 329, 2002-12. Moncada, S., Gryglewski, R., Bunting, S. and Vane, J. R.

(1976). An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature, 263, 663-5.

Moncada, S., Herman, A. G., Higgs, E. A. and Vane, J. R.

(1977). Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall: an explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res., 11, 323-44.

Nobunaga, T., Tokugawa, Y., Hashimoto, K., etal. (1996). Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol. Obstet. Investig., 41, 189-93. Palmer, R. M., Ferrige, A. G. and Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-6.

Palmer, R.M., Ashton, D. S. and Moncada, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-6.

Pascoal, I. F. and Umans, J. G. (1996). Effect of pregnancy on mechanisms of relaxation in human omental microvessels. Hypertension, 28, 183-7.

Pascoal, I.F., Lindheimer, M.D., Nalbantian-Brandt, C. and Umans, J. G. (1998). Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J. Clin. Investig., 101, 464-70.

Patrignani, P., Filabozzi, P. and Patrono, C. (1982). Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Investig., 69, 366-72.

Pedersen, A. K. and FitzGerald, G.A. (1984). Dose related kinetics of aspirin. N. Engl. J. Med., 311, 1206-11.

Penney, L.L., Frederick, R.J. and Parker, G.W. (1981). 17p-estradiol stimulation of uterine blood flow in oophorectomized rabbits with complete inhibition of uterine ribonucleic acid synthesis. Endocrinology, 109, 1672-6.

Petty, R. G. and Pearson, J. D. (1989). Endothelium - the axis of vascular health and disease. J. R. Coll. Physicians, 23, 92-101.

Phippard, A.F., Horvath, J.S., Glynn, E.M., et al. (1986). Circulatory adaptation to pregnancy: serial studies of haemodynamics, blood volume, renin and aldosterone in the baboon. J. Hypertens., 4, 773-9.

Pober, J. S. and Cotran, R. S. (1990). Cytokines and endothelial cell biology. Physiol. Rev., 70, 427-51.

Polliotti, B. M., Fry, A. G., Saller, D. N., et al. (2003). Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset pre-eclampsia. Obstet. Gynecol., 101, 1266-74.

Poston, L., McCarthy, A. L. and Ritter, J. M. (1995). Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol. Ther., 65, 215-39.

Poston, L. and Williams, D.J. (2000). The endothelium in human pregnancy. In Vascular Endothelium in Human Physiology and Pathophysiology, eds. P.J.T. Vallance and D.J. Webb. Harwood Academic Publishers, pp. 247-81.

Potter, J. M. and Nestel, P. J. (1979). The hyperlipidaemia of pregnancy in normal and complicated pregnancies. Am. J. Obstet. Gynecol., 133, 165-70.

Randall, M. D., Alexander, S. P. H., Bennett, T., etal. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 229, 114-20.

Redman, C.W., Sacks, G.P. and Sargent, I.L. (1999). Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol., 180, 499-506.

Rees, D.D., Palmer, R.M. and Moncada, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl Acad. Sci. USA, 86, 3375-8.

Resnick, N., Yahav, H., Schubert, S., etal. (2000). Signalling pathways in vascular endothelium activated by shear stress: relevance to atherosclerosis. Curr. Opin. Lipidol., 11, 167-77.

Ritter, J.M., Cockcroft, J.R., Doktor, H., et al. (1989). Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. Br. J. Clin. Pharm., 28, 573-9.

Roberts, J. M. and Redman, C. W. G. (1993). Pre-eclampsia: more than pregnancy-induced hypertension. Lancet, 341, 1447-51.

Roberts, J. M., Taylor, R. N., Musci, T. J., et al. (1989). Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol., 161, 1200-4.

Roberts, M., Lindheimer, M. D. and Davison, J. M. (1996). Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am. J. Physiol., 270, F338-43.

Robinson, L. J., Weremowicz, S., Morton, C. C. and Michel, T. (1994). Isolation and chromosomal localization of the human eNOS gene. Genomics, 19, 350-7.

Robson, S. C., Hunter, S., Boys, R. J. and Dunlop, W. (1989). Serial study of factors influencing changes in cardiac output during human pregnancy. Am. J. Physiol., 256, H1060-5.

Rogers, G.M., Taylor, R.N. and Roberts, J.M. (1988). Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am. J. Obstet. Gynecol., 159, 908-14.

Russell, K.R., Haynes, M.P., Sinha, D., et al. (2000a). Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intra-cellular signalling. Proc. Natl Acad. Sci. USA, 97, 5930-5.

Russell, K. S., Haynes, M. P., Caulin-Glaser, T., et al. (2000b). Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J. Biol. Chem., 275, 5026-30.

Sacks, G.P., Studena, K., Sargent, K., etal. (1998). Normal pregnancy and pre-eclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol., 179, 80-6.

Savvidou, M.D., Hingorani, A.D., Tsikas, D., etal. (2003). Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet, 361, 1511-17.

Savvidou, M. D., Kametas, N. A., Donald, A. E. and Nicolaides, K. H. (2000). Non-invasive assessment of endothelial function in normal pregnancy. Ultrasound Obstet. Gynecol., 15, 502-7.

Schafer, K., Muller, K., Hecke, A., et al. (2003). Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler. Thromb. Vasc. Biol., 23, 2097-103.

Schneider, F., Lutun, P., Balduf, J.J., etal. (1996). Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia. Acta Obstet. Gynecol. Scand., 75, 40-4.

Schobel, H. P., Fischer, T., Heuszer, K., Geiger, H. and Schmieder, R. E. (1996). Pre-eclampsia - a state of sympathetic overactivity. N. Engl. J. Med., 335, 1480-5.

Seligman, S.P., Buyon, J. P., Clancy, R.M., et al. (1994). The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol., 171, 944-8.

Sladek, S.M., Magness, R.R. and Conrad, K.P. (1997). Nitric oxide and pregnancy. Am. J. Physiol., 272, R441-63.

Smarason, A. K., Allman, K. G., Young, D. and Redman, C. W. G. (1997). Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br. J. Obstet. Gynaecol., 104, 538-43.

Sorensen, J., Secher, N. J. and Jespersen, J. (1995). Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. Acta Obstet. Gynecol. Scand., 74, 257-61.

Sudd, S.S., Gupta, I., Dhaliwal, L.K., et al. (1999). Serial plasma fibronectin levels in pre-eclamptic and normotensive women. Int. J. Gynecol. Obstet., 66, 123-8.

Taylor, R. N., Crombleholme, W. R., Friedman, S. A., et al. (1991). High plasma cellular fibronectin levels correlate with biochemical and clinical features of pre-eclampsia but cannot be attributed to hypertension alone. Am. J. Obstet. Gynecol., 165, 895-901.

Taylor, R.N., Grimwood, J., Taylor, R.S., et al. (2003). Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol., 188, 177-82.

Tran, C.T., Fox, M.F., Vallance, P., etal. (2000). Chromosomal localization, gene structure, and expression pattern of DDAH I: comparison with DDAH II and implications for evolutionary origins. Genomics, 68, 101-5.

Tsatsaris, V., Goffin, F., Munaut, C., et al. (2003). Overexpression of the soluble vascular endothelial growth factor in pre-eclamptic patients: pathophysio-logical consequences. J. Clin. Endocrinol. Metab., 88, 5555-63.

Vallance, P., Collier, J. and Moncada, S. (1989). Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet, 2, 997-1000.

Vallance, P., Leone, A., Calver, A., Collier, J. and Moncada, S. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 339, 572-5.

Vane, J. R. (1983). Clinical potential of prostacyclin. Adv. Prostaglandin Thromboxane Leukot. Res., 11, 457-61.

Vangoni, K.E., Shaw, C.E., Phernetton, T.M., etal. (1998). Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase. Am. J. Physiol., 275, H1845-55.

Vaughan, D.E., Lazos, S.A. and Tong, K. (1995). Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J. Clin. Invest., 95, 995-1001.

Vanhoutte, P.M. and Rimele, T.J. (1983). Role of endothelium in the control of vascular smooth muscle function. J. Physiol., 78, 681-6.

Vedernikov, Y.P., Belfort, M.A., Saade, G.R. and Mosie, K. J. (1995). Preeclampsia does not alter the response to endothelin-1 in human omental artery. J. Cardiovasc. Pharmacol., 3, S233-5.

Wang, Z.Q., Millatt, L.J., Heiderstadt, N.T., et al. (1999). Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension, 33, 96-101.

Weiner, C., Lizasoain, I., Baylis, S.A., et al. (1994a). Induction of calcium dependent nitric oxide synthases by sex hormones. Proc. Natl Acad. Sci. USA, 91, 5212-16.

Weiner, C.P., Knowles, R.G. and Moncada, S. (1994b). Induction of nitric oxide synthases early in pregnancy. Am. J. Obstet. Gynecol., 171, 838-43.

Williams, D.J. (2003). Physiological changes of normal pregnancy. In Oxford Textbook of Medicine (fourth edition), eds. D.A. Warrell, T.M. Cox, J.D. Firth and E.J. Benz. Oxford: Oxford University Press, chapter, 13.1, pp. 383-5.

Williams, D.J., Vallance, P. J., Neild, G.H., et al. (1997). Nitric oxide mediated vasodilatation in human pregnancy. Am. J. Physiol., 272, H748-52.

Williams, M.A., Farrand, A., Mittendorf, R., etal. (1999). Maternal second trimester serum tumour necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of pre-eclampsia. Am. J. Epidemiol., 149, 323-9.

Wolff, K., Nisell, H., Modin, A., et al. (1993). Contractile effects of endothelin 1 and endothelin 3 on myometrium and small intramyometrial arteries of pregnant women at term. Gynecol. Obstet. Investig., 36, 166-71.

Wolff, K., Kublickiene, K.R., Kublickas, M., etal. (1996a). Effects of endothelin-1 and the ETA receptor antagonist BQ-123 on resistance arteries from normal pregnant and pre-eclamptic women. Acta Obstet. Gynecol. Scand., 75, 432-8.

Wolff, K., Nisell, H., Carlstom, K., et al. (1996b). Endothe-lin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul. Peptides, 67, 211-16.

Wolff, K., Carlstom, K., Fyhrquist, F., et al. (1997). Plasma endothelin in normal and diabetic pregnancy. Diabetes Care, 20, 653-6.

Xu, D., Martin, P., St John, J., et al. (1996). Upregulation of endothelial and constitutive nitric oxide synthase in pregnant rats. Am. J. Physiol., 271, R1739-45.

Xu, H., Gonzalo, J.A., St Pierre, Y., et al. (1994). Leukocytosis and resistance to septic shock in intercellular adhesion molecule-1 deficient mice. J. Exp. Med.., 180, 95-109.

Yallampalli, C. and Garfield, R.E. (1993). Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of pre-eclampsia. Am. J. Obstet. Gynecol., 169, 1316-20.

Yang, J.C., Haworth, L., Sherry, R.M., et al. (2003). A randomised trial of bevacizumab, an antivascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med., 349, 427-34.

Yang, S., Bae, L. and Zhang, L. (2000). Estrogen increases eNOS and Nox release in human coronary artery endothelium. J. Cardiovasc. Pharmacol., 36, 242-7. Yoshimura, T., Yoshimura, M., Tabata, A., et al. (2000). Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J. Soc. Gynecol. Investig., 7, 238-41. Zemel, M.B., Zemel, P.C., Berry, S., et al. (1990). Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and pre-eclampsia in urban black women. N. Engl. J. Med., 323, 434-8.

Zhou, Y., McMater, M., Woo, K., et al. (2002). Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregu-lated in severe pre-eclampsia and haemolysis, elevated liver enzymes, and low platelet syndrome. Am. J. Path., 160, 1405-23.

Was this article helpful?

0 0
Staying Relaxed

Staying Relaxed

Start unlocking your hidden power with self hypnosis by relaxing and staying relaxed. This is just the audio you have been looking for to do just this.

Get My Free MP3 Audio

Post a comment